XTL Biopharmaceutica (Germany) Technical Analysis

H2K2 Stock  EUR 0.76  1.50  66.37%   
As of the 18th of April 2024, XTL Biopharmaceutica maintains the Downside Deviation of 8.2, risk adjusted performance of 0.0132, and Mean Deviation of 6.08. XTL Biopharmaceuticals technical analysis makes it possible for you to employ past prices and volume data with the intention to determine a pattern that calculates the direction of the company's future prices. Specifically, you can use this information to find out if the company will indeed mirror its model of past data patterns, or the prices will eventually revert. We were able to collect data for nineteen technical drivers for XTL Biopharmaceuticals, which can be compared to its peers. Please check out XTL Biopharmaceuticals standard deviation, information ratio, treynor ratio, as well as the relationship between the variance and jensen alpha to decide if XTL Biopharmaceuticals is priced some-what accurately, providing market reflects its latest price of 0.76 per share.

XTL Biopharmaceutica Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as XTL, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to XTL
  
XTL Biopharmaceutica's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
XTL Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of XTL Biopharmaceutica technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of XTL Biopharmaceutica trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

XTL Biopharmaceuticals Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of XTL Biopharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.

XTL Biopharmaceuticals Trend Analysis

Use this graph to draw trend lines for XTL Biopharmaceuticals. You can use it to identify possible trend reversals for XTL Biopharmaceutica as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual XTL Biopharmaceutica price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

XTL Biopharmaceutica Best Fit Change Line

The following chart estimates an ordinary least squares regression model for XTL Biopharmaceuticals applied against its price change over selected period. The best fit line has a slop of   0.04  , which means XTL Biopharmaceuticals will continue generating value for investors. It has 122 observation points and a regression sum of squares at 51.12, which is the sum of squared deviations for the predicted XTL Biopharmaceutica price change compared to its average price change.

About XTL Biopharmaceutica Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of XTL Biopharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of XTL Biopharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on XTL Biopharmaceuticals price pattern first instead of the macroeconomic environment surrounding XTL Biopharmaceuticals. By analyzing XTL Biopharmaceutica's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of XTL Biopharmaceutica's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to XTL Biopharmaceutica specific price patterns or momentum indicators. Please read more on our technical analysis page.

XTL Biopharmaceutica April 18, 2024 Technical Indicators

Most technical analysis of XTL help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for XTL from various momentum indicators to cycle indicators. When you analyze XTL charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in XTL Biopharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for XTL Stock analysis

When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
CEOs Directory
Screen CEOs from public companies around the world
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Please note, there is a significant difference between XTL Biopharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if XTL Biopharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XTL Biopharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.